| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Financial Officer | EVP &CFO
3 companies
Maynard Ryan D is an EVP &CFO at RIGEL PHARMACEUTICALS INC with holdings across 3 companies. Recent SEC Form 4 filings include 1 buy and 3 sells.
Estimated insider holdings value: $2.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 12, 2024 | IOVA Iovance Biotherapeutics, Inc. | Director | Sale+OE | 50,000 | $10.06 | $503,000.00 | -87.0% | -45.1% | -73.8% | |
| Feb 8, 2023 | TVRD Tvardi Therapeutics, Inc. | Chief Financial Officer | Sell | 5,488 | $0.53 | $2,908.64 | -40.7% | -64.2% | -95.5% | |
| May 31, 2022 | IOVA Iovance Biotherapeutics, Inc. | Director | Buy | 7,500 | $6.75 | $50,587.50 | New | +58.5% | +29.5% | |
| Nov 3, 2017 | RIGL Rigel Pharmaceuticals Inc | EVP &CFO | Sale+OE | 100,000 | $3.90 | $390,000.00 | -100% | - | - |